Parkinson's Disease Market Research Reports & Industry Analysis
As the disease progresses, the shaking, or tremor, which affects the majority of PD patients may begin to interfere with daily activities. Other symptoms may include depression and other emotional changes; difficulty in swallowing, chewing, and speaking; urinary problems or constipation; skin problems; and sleep disruptions. There are currently no blood or laboratory tests that have been proven to help in diagnosing sporadic PD. Therefore the diagnosis is based on medical history and a neurological examination. The disease can be difficult to diagnose accurately.
There is no cure for PD, but a variety of medications provide dramatic relief from the symptoms. Usually, patients are given levodopa combined with carbidopa. Carbidopa delays the conversion of levodopa into dopamine until it reaches the brain. Anticholinergics may help control tremor and rigidity. Other drugs, such as bromocriptine, pramipexole, and ropinirole, mimic the role of dopamine in the brain, causing the neurons to react as they would to dopamine. An antiviral drug, amantadine, also appears to reduce symptoms.
Parkinson's Disease Industry Research & Market Reports
-
2025 Diseases of the Nervous System Global Market Size & Growth Report with Updated Country Recession Risk Forecasts
... 22 subregions, and 195 countries. Figures are from 2013 through 2024, with forecasts for 2025 and the next 5 years. The historical data utilizes in-depth survey results from companies selling diseases of the nervous system ... Read More
-
Neurodegenerative Drugs
... CAGR of 6.8% over the analysis period 2024-2030. Dopamine Agonist, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$25.7 Billion by the end of the analysis ... Read More
-
Neuromodulation Market Report by Technology (Internal Neuromodulation, External Neuromodulation), Biomaterial (Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials), Application (Parkinson's Disease, Epilepsy, Depression, Dystonia, Pain Management, and Others), and Region 2025-2033
... market is experiencing robust growth, driven by the increasing prevalence of chronic and neurological disorders, imposition of favorable regulatory environment, rising expenditure on healthcare, significant advancements in device technology, and growing demand for minimally invasive ... Read More
-
Neurological Biomarkers Market Size, Share & Trends Analysis Report By Application (Alzheimer’s, Parkinson’s, Multiple Sclerosis, Autism), By Type, By End Use, By Region, And Segment Forecasts, 2025 - 2030
... report by Grand View Research, Inc. Increased funding for R&D of neurological biomarkers to boost development of new drugs is expected to impel market growth. National Institute of Neurological Disorders and Stroke provides funding opportunities ... Read More
-
Deep Brain Stimulation Devices
... 2030, growing at a CAGR of 8.5% over the analysis period 2024-2030. Dual-Channel, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$1.7 Billion by the end ... Read More
-
Neurological Biomarkers for Alzheimer`s and Parkinson`s Diseases
... expected to reach US$16.4 Billion by 2030, growing at a CAGR of 8.8% over the analysis period 2024-2030. The U.S. Market is Estimated at US$2.8 Billion While China is Forecast to Grow at 8.3% CAGR ... Read More
-
Parkinson’s Disease Drugs
... at a CAGR of 6.5% over the analysis period 2024-2030. Oral, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$4.6 Billion by the end of the ... Read More
-
Neuroregeneration Therapy Market, By Type of Neuroregeneration Therapy (Stem Cell Therapy, Gene Therapy, Pharmacological Therapy, Neurostimulation Therapy, Others), By Indication (Spinal Cord Injury, Stroke, Traumatic Brain Injury, Parkinson\\\'s Disease, Alzheimer\\\'s Disease, Multiple Sclerosis, Peripheral Nerve Injury, Others), By Mode of Administration (Oral, Injectable, Implantable, Others), By Age Group (Pediatric, Adult, Geriatric), By End User (Hospitals, Specialty Clinics, Research Institutes, Rehabilitation Centers, Others), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)
... involves the synthesis of new neurons and connections, providing additional resources to substitute the damaged ones. Neuroregeneration is not just about physical recovery; it's also a vital mechanism for maintaining cognitive functions. It plays a ... Read More
-
Medical Marijuana Market Size, Share, and Outlook, 2025 Report- By Product (Flower, Oil & Tinctures ), By Application (Cancer, Chronic Pain, Depression and Anxiety, Arthritis, Diabetes, Glaucoma, Migraines, Epilepsy, Multiple Sclerosis, AIDS, Amyotrophic Lateral Sclerosis, Alzheimer’s Disease, Post-Traumatic Stress Disorder (PTSD), Parkinson's Disease, Tourettes, Others), 2021-2032
... growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Medical Marijuana segments across 22 countries from 2021 to 2032. ... Read More
-
Medical Foods Market Size, Share, and Outlook, 2025 Report- By Route of Administration (Oral, Enteral), By Product (Powder, Pills, Liquid, Other), By Application (Chronic Kidney Disease, Minimal Hepatic Encephalopathy, Chemotherapy Induced Diarrhea, Pathogen Related Infections, Diabetic Neuropathy, ADHD, Depression, Alzheimer's Disease, Nutritional Deficiency, Orphan Diseases, Wound Healing, Chronic Diarrhea, Constipation Relief, Protein Booster, Dysphagia, Pain Management, Parkinson's Disease, Epilepsy, Severe Protein Allergy, Cancer, Cachexia, Others), By Sales Channel (Online Sales, Retail Sales, Institutional Sales), 2021-2032
... growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Medical Foods segments across 22 countries from 2021 to 2032. ... Read More
-
Neurology Clinical Trials Market Size, Share, and Outlook, 2025 Report- By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design (Interventional, Observational, Expanded Access), By Indication (Epilepsy, Parkinson's Disease (PD), Huntington's Disease, Stroke, Traumatic Brain Injury (TBI), Amyotrophic Lateral Sclerosis (ALS), Muscle regeneration, Others), 2021-2032
... poised to keep growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Neurology Clinical Trials segments across 22 countries ... Read More
-
Immunoassay for Neurological Biomarkers Market Size, Share, and Outlook, 2025 Report- By Product (Instruments, Reagents, Services), By Disease (Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Others), By Application (In Vitro Diagnostics Application, Research Application), 2021-2032
... business that is poised to keep growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Immunoassay for Neurological Biomarkers ... Read More
-
Neurological Biomarkers Market Size, Share, and Outlook, 2025 Report- By Type (Genomic, Proteomic, Metabolomic, Imaging, Others), By Application (Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Autism Spectrum Disorder, Others), By End-user (Hospital & Hospital Laboratories, Independent clinical diagnostic centers, Research Organizations, Others), 2021-2032
... growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Neurological Biomarkers segments across 22 countries from 2021 to 2032. ... Read More
-
Active Wheelchair Market Size, Share, and Outlook, 2025 Report- By Product (Manual Wheelchairs, Power Wheelchairs), By Indication (Alzheimer’s Disease, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis, Diabetes, Cerebral Palsy, Muscular Dystrophy, Parkinson’s Disease, Scoliosis, Spina Bifida, Spinal Cord Injury, Others), 2021-2032
... growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Active Wheelchair segments across 22 countries from 2021 to 2032. ... Read More
-
Continence Care Market Size, Share, and Outlook, 2025 Report- By Product (Urinary Catheters, Catheter Maintenance/Care, Urinary Bags), By Application (Diabetes, Strokes, BPH, Alzheimer, Cerebral Palsy, Parkinson, Prostate cancer, Spinal Cord Injury, Bladder Cancer, Multiple sclerosis, Spina Bifida, Others), By Bag Usage, Sterile bags, Non-sterile bags), By End-User (Home Care Settings, Hospitals, Others), 2021-2032
... growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Continence Care segments across 22 countries from 2021 to 2032. ... Read More
-
Deep Brain Stimulation in Parkinson's Disease Market Size, Share, and Outlook, 2025 Report- By Product (Single Channel, Dual Channel), By End-User (Hospitals, Neurology Clinics, Ambulatory Surgical Centers, Research Centers), 2021-2032
... Parkinson's Disease market is a thriving business that is poised to keep growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast ... Read More
-
Parkinson's Disease Monitoring Device Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type
... Essential in neurology, they feature real-time data collection and portability. Available as wrist monitors, ankle monitors, and other types, they serve hospitals and clinics. The market is driven by rising Parkinson’s prevalence, aging populations, and ... Read More
-
Global Blarcamesine Market, By Route of Adminsitration (Oral, Parenteral), By Application (Alzheimer\\\'s Disease, Parkinson\\\'s Disease , Dementia, Rett Syndrome, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa).
... sigma-1 receptor forms heterodimers with many other membrane receptors and, as such, influences multiple cellular pathways and physiological processes. Blarcamesine reportedly binds the sigma-1 receptor in the high nanomolar and the muscarinic receptor in the ... Read More
-
NEUROTECHNOLOGY MARKET - GROWTH, TRENDS, AND FORECASTS (2025 - 2030)
... are driving the growth of the neuroelectronics market include the increasing prevalence of neurological disorders, rapid advancements in neuroscience and technology, and the rising demand for improved treatment options. The rising incidence of neurological disorders, ... Read More
-
2025 Global Deep Brain Stimulation In Parkinson'S Disease Market Industry (2031 Outlook)
... market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for 46 countries. The report also features written analysis on market definitions, market segments, ... Read More
-
Asia Pacific Medical Exoskeleton Market Forecast to 2031 - Regional Analysis - by Component (Hardware and Software), Type (Powered Exoskeleton and Passive Exoskeleton), Extremity (Lower Body Exoskeleton, Upper Body Exoskeleton, and Full Body Exoskeleton), Application (Spinal Cord Injury, Multiple Sclerosis, Stroke, Cerebral Palsy, Parkinson's Disease, and Others), Mobility (Mobile Exoskeleton and Stationary Exoskeleton), and End Users (Rehabilitation Centers, Physiotherapy Centers, Long Term Care Centers, Homecare Settings, and Others)
... to 2031. Increasing Prevalence of SCI Boosts Asia Pacific Medical Exoskeleton Market Reduced physical activity and the predominance of seated activities can lead to severe physical and psychological deterioration in people suffering from SCI. Secondary ... Read More
-
South & Central America Medical Exoskeleton Market Forecast to 2031 - Regional Analysis - by Component (Hardware and Software), Type (Powered Exoskeleton and Passive Exoskeleton), Extremity (Lower Body Exoskeleton, Upper Body Exoskeleton, and Full Body Exoskeleton), Application (Spinal Cord Injury, Multiple Sclerosis, Stroke, Cerebral Palsy, Parkinson's Disease, and Others), Mobility (Mobile Exoskeleton and Stationary Exoskeleton), and End Users (Rehabilitation Centers, Physiotherapy Centers, Long Term Care Centers, Homecare Settings, and Others)
... from 2023 to 2031. Increasing Prevalence of SCI Fuels South & Central America Medical Exoskeleton Market Reduced physical activity and the predominance of seated activities can lead to severe physical and psychological deterioration in people ... Read More
-
Europe Medical Exoskeleton Market Forecast to 2031 - Regional Analysis - by Component (Hardware and Software), Type (Powered Exoskeleton and Passive Exoskeleton), Extremity (Lower Body Exoskeleton, Upper Body Exoskeleton, and Full Body Exoskeleton), Application (Spinal Cord Injury, Multiple Sclerosis, Stroke, Cerebral Palsy, Parkinson's Disease, and Others), Mobility (Mobile Exoskeleton and Stationary Exoskeleton), and End Users (Rehabilitation Centers, Physiotherapy Centers, Long Term Care Centers, Homecare Settings, and Others)
... 2031. Growing Incidence of Stroke and Musculoskeletal Drives Europe Medical Exoskeleton Market Despite the advancements in the medical industry, stroke continues to be a major public health issue. Stroke ranks second in the world in ... Read More
-
Middle East & Africa Medical Exoskeleton Market Forecast to 2031 - Regional Analysis - by Component (Hardware and Software), Type (Powered Exoskeleton and Passive Exoskeleton), Extremity (Lower Body Exoskeleton, Upper Body Exoskeleton, and Full Body Exoskeleton), Application (Spinal Cord Injury, Multiple Sclerosis, Stroke, Cerebral Palsy, Parkinson's Disease, and Others), Mobility (Mobile Exoskeleton and Stationary Exoskeleton), and End Users (Rehabilitation Centers, Physiotherapy Centers, Long Term Care Centers, Homecare Settings, and Others)
... from 2023 to 2031. Increasing Technological Advancements and Rising Investments Bolster Middle East & Africa Medical Exoskeleton Market Globally, people strive for better health and do not compromise with low-quality products. Owing to this, continuous ... Read More
-
North America Medical Exoskeleton Market Forecast to 2031 - Regional Analysis - by Component (Hardware and Software), Type (Powered Exoskeleton and Passive Exoskeleton), Extremity (Lower Body Exoskeleton, Upper Body Exoskeleton, and Full Body Exoskeleton), Application (Spinal Cord Injury, Multiple Sclerosis, Stroke, Cerebral Palsy, Parkinson's Disease, and Others), Mobility (Mobile Exoskeleton and Stationary Exoskeleton), and End Users (Rehabilitation Centers, Physiotherapy Centers, Long Term Care Centers, Homecare Settings, and Others)
... to 2031. Rising Number of Strategic Initiatives Fuels North America Medical Exoskeleton Market Small and big companies operating in the medical exoskeleton market adopt various strategies such as geographic expansion, new product launches, and technological ... Read More